e-learning
resources
Madrid 2019
Monday, 30.09.2019
Novel methods, diagnostics and biomarkers in chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antibiotics and the microbiome in asthmatic patients
O. O'Carroll (Dublin, Ireland), A. Mcgowan (Dublin, Ireland), C. Gough (Dublin, Ireland), W. Shah (Dublin, Ireland), C. Burke (Dublin, Ireland)
Source:
International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Session:
Novel methods, diagnostics and biomarkers in chronic lung diseases
Session type:
Thematic Poster
Number:
2346
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. O'Carroll (Dublin, Ireland), A. Mcgowan (Dublin, Ireland), C. Gough (Dublin, Ireland), W. Shah (Dublin, Ireland), C. Burke (Dublin, Ireland). Antibiotics and the microbiome in asthmatic patients. 2346
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Respiratory physiology
Related content which might interest you:
The study of airway microbiome and mycobiome of COPD and AECOPD patients
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
The airway microbiota and exacerbations of COPD
Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020
Year: 2020
Anti-IL-5 therapy and the airway microbiome in asthma.
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020
Antibiotics in exacerbations of asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
The intestinal microflora in healthy and wheezing infants
Source: Eur Respir J 2005; 26: Suppl. 49, 693s
Year: 2005
Gut microbiome in COPD
Source: International Congress 2016 – Microbiome in health and in disease
Year: 2016
Bacterial dysbiosis in pediatric lung diseases such as asthma and CF
Source: Virtual Congress 2020 – Bugs secret's: the way the microbiome changes our future
Year: 2020
Antibiotics use for asthma exacerbation in Japanese geriatric patients
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
The impact of smoking on airway microbiome and mycobiome of COPD/AECOPD patients
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Bacterial infection in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 159s
Year: 2002
The effect of exacerbations on the airway microbiota in children with non-CF bronchiectasis
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019
A study of the airway mycobiome in COPD patients and controls
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019
Gut microbiota in wheezing preschool children and the development of childhood asthma
Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors
Year: 2019
Inhaled corticosteroids, bacterial load and the lung microbiome in COPD
Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection
Year: 2019
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Upper airways diseases in allergic and nonallergic asthma patients and nonasthmatic subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 589s
Year: 2004
Spectrum of sputum microflora during infectious exacerbation of bronchial asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Targeting microbes and dysbiosis in severe asthma
Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players?
Year: 2019
The lower airways microbiome in patients with IPF and COPD
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Penetration of moxifloxacin in bronchial secretions in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept